Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer’s and Parkinson’s diseases

  • Elizabeth M. Rhea
  • , Alice Babin
  • , Peter Thomas
  • , Mohamed Omer
  • , Riley Weaver
  • , Kim Hansen
  • , William A. Banks
  • , Konrad Talbot

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number2292461
JournalTissue Barriers
Volume12
Issue number4
DOIs
StatePublished - Oct 2024

ASJC Scopus Subject Areas

  • Biochemistry
  • Histology
  • Cell Biology

Keywords

  • Alzheimer’s disease
  • Parkinson’s disease
  • glucagon-like peptide -1 receptor
  • incretin receptor agonists
  • pharmacokinetics
  • Parkinson Disease/drug therapy
  • Glucagon-Like Peptide 1/analogs & derivatives
  • Immunoglobulin Fc Fragments/pharmacology
  • Male
  • Blood-Brain Barrier/metabolism
  • Glucagon-Like Peptides/analogs & derivatives
  • Animals
  • Alzheimer Disease/drug therapy
  • Mice
  • Recombinant Fusion Proteins/pharmacokinetics
  • Brain/metabolism

Cite this